New studies and schemes
Salivary Cortisol
Labquality is announcing a new EQA scheme for Salivary Cortisol. The scheme is suitable for different assays measuring salivary cortisol in clinical samples. The registration for this pilot study is closed.
Chemokine CXCL13
Labquality is announcing a new EQA scheme for Chemokine CXCL13, a biomarker for neuroborreliosis. Pilot round includes two samples that should be analysed as regular patient samples. The registration for this pilot study is closed.
Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis
Labquality is announcing a new EQA scheme for Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis. The scheme is suitable for different ELISA assays measuring the cell-mediated response to specific tuberculosis antigens in whole blood. The sample sets are sold out and we can only accept registrations for a waiting list. The registration for this pilot study is closed.
Faecal Elastase
Labquality is announcing a new EQA scheme for faecal elastase. In the pilot study, two lyophilized faecal samples of different elastase concentration will be included. The registration for this pilot study is closed.
Fungal infections, nucleic acid detection
Labquality is announcing a new EQA scheme for direct nucleic acid detection of fungal infections. The scheme samples may contain yeasts, moulds and dermatophytes and it will be suitable for different nucleic acid test panels. The registration for this pilot study is closed.
Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection
Labquality is announcing a new EQA scheme for nucleic acid detection of Mycobacterium tuberculosis including samples containing rifampisin and isoniazid resistance. The scheme is suitable for nucleic acid test panels and scoring is based on the qualitative interpretation. The registration for this pilot study is closed.
Adrenocorticothropic hormone ACTH and Cortisol
Labquality is announcing a new pilot study for two hormones ACTH and cortisol. The registration for this pilot study is closed.
HSV1&2 / VZV / T. pallidum, nucleic acid detection
Labquality is announcing a new pilot study for nucleic acid detection of four pathogens included in a four-plex sample. The included pathogens are HSV1&2, VZV and Treponema pallidum. The registration for this pilot study is closed.
EQA for next-generation sequencing methods
We are developing external quality assessments for NGS methods in microbiology. If you are interested, please contact us!
Contact us for more information!
Heidi Berghäll
Kristel Virtanen
Related Services
External Quality Assessment
Labquality’s EQA schemes are designed for medical laboratories and point-of-care testing sites to monitor and improve their performance.
Integrated EQA Service
Integrated EQA service is a completely new approach to external quality assessment.
EQA Programme 2023
Labquality’s external quality assessment program (EQAS) is aimed at medical laboratories and point-of-care testing sites.
Labquality’s Partners in EQA
Labquality has EQA partners in more than 40 countries in Europe, South America, South-East Asia and the Middle East. Please find the contact details here.
External Quality Assessment Services
Our external quality assessment service programme includes more than 160 EQA schemes, covering the key specialities of laboratory medicine.
EQAS for preanalytical phase
Labquality’s preanalytical external quality assessment schemes provide a unique means to assess a larger part of the total laboratory testing cycle.